The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro | 2020/06/01 | English | 1,275 |
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade | 2020/04/01 | English | 1,151 |
Present and future arboviral threats | 2010/02/01 | English | 928 |
Favipiravir (T-705), a novel viral RNA polymerase inhibitor | 2013/11/01 | English | 718 |
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro | 2020/06/01 | English | 624 |
The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds | 2015/03/01 | English | 565 |
Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical syndrome and genetic diversity | 2013/10/01 | English | 525 |
Coronavirus membrane fusion mechanism offers a potential target for antiviral development | 2020/06/01 | English | 499 |
Zika virus: History, emergence, biology, and prospects for control | 2016/06/01 | English | 489 |
Antiviral effect of catechins in green tea on influenza virus | 2005/11/01 | English | 452 |
Protease inhibitors targeting coronavirus and filovirus entry | 2015/04/01 | English | 417 |
Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein | 2018/01/01 | English | 415 |
Crimean?Congo hemorrhagic fever | 2004/12/01 | English | 386 |
Of chloroquine and COVID-19 | 2020/05/01 | English | 383 |
Identification of natural compounds with antiviral activities against SARS-associated coronavirus | 2005/07/01 | English | 379 |
Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds | 2005/10/01 | English | 360 |
The flavivirus NS1 protein: Molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker | 2013/05/01 | English | 356 |
Nitazoxanide: A first-in-class broad-spectrum antiviral agent | 2014/10/01 | English | 350 |
Type 1 interferons as a potential treatment against COVID-19 | 2020/06/01 | English | 346 |
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model | 2014/05/01 | English | 342 |
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction | 2007/05/01 | English | 340 |
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase | 2019/09/01 | English | 339 |
The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold | 2018/06/01 | English | 335 |
Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy | 2013/09/01 | English | 326 |
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections | 2009/06/01 | English | 325 |
Arbidol as a broad-spectrum antiviral: An update | 2014/07/01 | English | 321 |
The SARS coronavirus nucleocapsid protein – Forms and functions | 2014/03/01 | English | 318 |
Antiviral drugs for cytomegalovirus diseases | 2006/09/01 | English | 311 |
Herpes simplex encephalitis: Adolescents and adults | 2006/09/01 | English | 308 |
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic | 2010/01/01 | English | 306 |